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Abstract  
 
Robust protocols for directed differentiation of human pluripotent cells are required to 
determine whether mechanisms operating in model organisms are relevant to our own 
development. Recent work in vertebrate embryos has identified neuromesodermal 
progenitors as a bipotent cell population that contributes to paraxial mesoderm and spinal 
cord. However, precise protocols for in vitro differentiation of human spinal cord progenitors 
are lacking. Informed by signalling in amniote embryos, we show here that transient dual-SMAD 
inhibition, together with retinoic acid (dSMADi-RA), provides rapid and reproducible induction 
of human spinal cord progenitors from neuromesodermal progenitor-like cells. Using CRISPR-
Cas9 to engineer human embryonic stem cells with a GFP-reporter for neuromesodermal 
progenitor-associated gene Nkx1.2 we facilitate selection of this cell population. RNA-
sequencing was then used to identify human and conserved neuromesodermal progenitor 
transcriptional signatures, validate this differentiation protocol and implicate new 
pathways/processes in human neural differentiation. This optimised protocol, novel reporter 
line and transcriptomic data are useful resources with which to dissect molecular mechanisms 
regulating human spinal cord generation and allow scale-up of distinct cell populations for 
global analyses, including proteomic, biochemical and chromatin interrogation. 
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Introduction 
Head and trunk nervous systems have distinct developmental origins. Head or anterior neural 
progenitors are derived from the epiblast rostral to the primitive streak and will form regions 
of the brain. In contrast, progenitors of trunk or posterior neural tissue (posterior hindbrain 
and spinal cord) arise from epiblast adjacent to and within the anterior primitive streak (known 
as caudal lateral epiblast (CLE) and node streak border (NSB), respectively) (Wilson et al. 2009) 
(Fig. 1A). In recent years, evidence has accrued which indicates that, unlike anterior, posterior 
neural tissue is generated via an intermediary neuromesodermal progenitor (NMP), which 
contributes paraxial mesoderm as well as posterior neural tube (reviewed (Tzouanacou et al. 
2009; Gouti et al. 2015; Henrique et al. 2015; Tsakiridis and Wilson 2015). Human, mouse and 
chick embryos as well as in vitro NMPs are identified by co-expression of early neural (Sox2) 
and mesodermal Brachyury (Bra) proteins, but as yet lack unique molecular markers (Olivera-
Martinez et al. 2012; Gouti et al. 2014; Turner et al. 2014; Henrique et al. 2015; Tsakiridis and 
Wilson 2015). While we are beginning to uncover how mouse NMPs are regulated, human 
NMP-like cells and their derivatives are less well characterised, in part because this requires 
creation of robust in vitro models. 
Most in vitro differentiation protocols are informed by our understanding of how the 
cell type of interest is generated during embryonic development. In the caudal end of amniote 
embryos, FGF and Wnt signalling act in a positive feedback loop to maintain the elongation of 
the body axis (Aulehla et al. 2003; Olivera-Martinez and Storey 2007; Wilson et al. 2009). FGF 
signalling also promotes expression of genes characteristic of CLE including the transcription 
factor Nkx1.2 (Delfino-Machin et al. 2005; Sasai et al. 2014). Nkx1.2 expression extends into 
the preneural tube (PNT) (Spann et al. 1994; Schubert et al. 1995; Rodrigo-Albors et al. 2016). 
Here preneural progenitors (PNPs) downregulate Bra, transcribe the early neural gene Sox2, 
but as yet do not express neurogenic genes such as Neurog2 and Pax6 (Scardigli et al. 2001; 
Scardigli et al. 2003; Bel-Vialar et al. 2007)(Fig 1A). Retinoic acid synthesized in neighbouring 
paraxial mesoderm mediates the transition from PNPs, repressing expression of Fgf8 and Wnts 
8a/c and 3a (Shum et al. 1999; Diez del Corral et al. 2003; Sirbu and Duester 2006; Olivera-
Martinez and Storey 2007; Cunningham et al. 2015) and is then further required for neurogenic 
gene transcription (Diez del Corral et al. 2003; Ribes et al. 2008) 
In addition, to the involvement of these signalling pathways in NMP regulation, 
inhibition of BMP signalling is required for Sox2 transcription in the CLE/NSB (Takemoto et al. 
2006). In mouse and chick embryos, various BMP and TGF antagonists (Noggin, Chordin and 
Follistatin) are expressed in the anterior primitive streak, emerging notochord and newly 
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formed somites close to posterior neural tissue (Albano et al. 1994; Liem et al. 2000; Chapman 
et al. 2002). Considered together with the requirement for BMP antagonism for anterior neural 
induction (Hemmati Brivanlou and Melton 1997; Harland 2000; Kuroda et al. 2004; Linker and 
Stern 2004) the experiments of Takemoto et al. indicate an on-going requirement for BMP 
antagonism during the progressive generation of the posterior nervous system. 
 Almost all in vitro protocols for making NMP or NMP-like cells from mouse and human 
embryonic stem cells (hESCs) involve exposure to various durations of Wnt agonist with or 
without FGF (Gouti et al. 2014; Tsakiridis et al. 2014; Turner et al. 2014; Lippmann et al. 2015) 
and one approach has included TGF inhibition (to promote loss of self-renewal in human ESC 
and repress mesendoderm differentiation, after (Chambers et al. 2009; Denham et al. 2015). It 
is well established that efficient induction of anterior neural tissue from hESCs is achieved by 
exposure to inhibitors of both TGF and BMP signalling (known as dual-SMAD 
inhibition)(Chambers et al. 2009). However, a role for BMP inhibition in the differentiation of 
neural tissue from NMPs in vitro has not been assessed. Here we show that neural 
differentiation from human NMP-like cells is promoted by transient dual-SMAD inhibition. We 
deploy CRISPR-Cas9 engineering to make a reporter for enrichment for human NMP-like cells 
and provide the first transcriptomic profiling of this cell population and derived spinal cord 
progenitors. 
 
Results and Discussion 
Robust differentiation of human NMP-like cells into posterior neural progenitors by inclusion of 
transient dual SMAD inhibition 
In human ESCs, the simplest approach to make NMP-like cells involves removal of self-renewal 
conditions and exposure to FGF and the Wnt agonist CHIR99021 for 3 days. The cells generated 
in this way were then differentiated into neural progenitors by day 6, following replating and 
culture in basal media alone (Gouti et al. 2014). We first assessed the reproducibility of this 
protocol to generate Pax6 expressing neural progenitors. Culturing hESCs in Neurobasal 
supplemented with 1x N2, 1x B27 medium bFGF (20 ng ml-1)and CHIR99021 (3M) for 3 days 
readily generated Sox2/Bra co-expressing NMP-like cells (Figs. S1A, B). However, subsequent 
differentiation after cell dissociation and re-plating in just Neurobasal / 1x N2 / 1x B27 at the 
end of day 3 (D3), did not generate Pax6 positive cells by end of day 6 (D6) (assessed in two 
hESC lines, SA121 and H9) (Figs S1 C, D). We then carried out a series of experiments aimed at 
inducing prompt neural differentiation as indicated by expression of Pax6 by D6. Introduction 
of all-trans retinoic acid (RA) 100nM from the beginning of the neural differentiation protocol 
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on day 4 (D4) was not sufficient in either cell line (Figs S1C,D). This inability to induce prompt 
Pax6 expression from NMP-like cells might reflect inherent differences between hESC lines, but 
may also involve variant culture conditions, including the extent of cell dissociation on re-
plating following NMP-like cell induction. This may influence cell-cell signalling and could mimic 
inhibition of BMP signalling, as reported on dissociation of Xenopus animal cap ectoderm 
(Wilson and Hemmati-Brivanlou 1995). Furthermore, exposure to dual SMAD inhibitors 
(dSMADi) and so attenuation of BMP and TGF receptor type 1 signalling is known to promote 
anterior neural differentiation of hES cells following removal of self-renewal conditions 
(Chambers et al. 2009). Informed by the timing of exposure to endogenous TGF inhibitors 
experienced by cells in the CLE and PNT in the amniote embryo (Fig. 1A), we next introduced 
Noggin 50 ng/ml and the TGF receptor type 1 inhibitor SB431542 10 M from the beginning 
of D3 to the end of D4. This step did not alter induction of NMP-like cells on D3, (Fig. 1B’ and 
see flow cytometry data Fig. S2) and in combination with subsequent exposure to RA from D4, 
robust Pax6 expression was induced by D6 (Fig. 1C). Importantly, inclusion of either Noggin or 
SB431542 alone with RA was not effective (Fig. 1D), indicating that dual SMAD inhibition is 
required to augment neural differentiation in this context. The reproducibility of this protocol 
(Fig. 1B) was further demonstrated by rapid induction of Pax6 in a hiPSC line (Fig. S3: ChiPS4). 
 
To characterize this dSMADi-RA differentiation protocol we analyzed the expression 
dynamics of key cell state marker genes using quantitative reverse transcription PCR (RT-qPCR). 
Pluripotency genes Nanog and Oct4 were dramatically reduced from hESC to D3(NMP-like) and 
transcripts were lost quickly as these cells differentiated (Fig. 2A), as observed in mouse and 
chick embryo and mouse ESC-derived NMPs (Tsakiridis et al., 2014, Gouti et al., 2014). 
D3(NMPs) were characterized by high-level Bra and Cdx2 transcription (Fig 2B). As in mouse ES 
cell-derived NMPs, Sox2 transcripts were lower in D3(NMP-like cells) than in hESCs, despite 
high-level Sox2 protein in mNMPs (Gouti et al 2014; Turner et al 2014) (Fig. 1F, 2B). Cdx genes 
regulate signalling that maintains the mouse NMP cell state and also induce expression of 
posterior Hox genes, which confer anterior-posterior identity (Young and Deschamps 2009; 
Young et al. 2009; Gouti et al. 2017). NMP-like cells expressed Hoxb4 and little Hoxc6 (Fig. 2C) 
and together with subsequent RNASeq analysis (see below) which revealed transcription of Hox 
gene paralogues only within a range from a1 to a7 on D3, this suggests that these cells are 
equivalent to mouse embryo E7.5-8.5 CLE/NSB cells, which co-express Hox genes across this 
range (Huang et al. 1998; Yu et al. 1998). The anterior boundary of Hox a7 defines 
cervical/thoracic boundary at later stages, suggesting that hNMP-like cells and their derivatives 
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generated with this protocol possess an anteroposterior identity in this region (Fig. 2C). In the 
embryo, differentiation from NMPs to neural progenitors involves downregulation of Bra and 
entry into a transitional preneural cell state (Fig. 1A), which is characterized by persisting 
expression of Wnt8a/c and Nkx1.2 (Fig. 2D).  As these genes decline Pax6 is then transcribed, 
rising to a peak at D8 (Fig. 2E). This suggests that neural progenitors arise between D5 and D8. 
This protocol therefore provides an assay in which to investigate the human NMP-like cell state 
and how this alters to form spinal cord progenitors. 
 
Generation of a human Nkx1.2 reporter cell line  
Cell populations generated in vitro are inevitably heterogeneous and so we next made a 
reporter line that could be used to enrich for NMP-like cells. We took advantage of CRISPR/Cas9 
technology (Komor et al. 2017) to engineer H9 hESCs to express GFP under the control of the 
endogenous Nkx1.2 promoter. This homeo-domain containing transcription factor is highly 
expressed in NMPs (CLE and NSB) in the mouse embryo and is detected at lower levels in the 
cells becoming neural progenitors (preneural cells) or cells ingressed into the primitive streak 
and is then lost in neural and mesodermal progenitors (Fig. 1A, 2D) (Spann et al. 1994; Schubert 
et al. 1995; Rodrigo-Albors et al. 2016). We reasoned that selection for high Nkx1.2 expression 
on D3 when Bra transcripts are high would enrich for NMP-like cells. To this end a GFP-T2A 
sequence (Kim et al. 2011) was knocked-in to the Nkx1.2 locus in-frame just upstream of exon1 
(Fig 2F and see Methods). Correct targeting was confirmed by PCR across the integration site 
and subsequent fragment sequencing (Figs 2G, S4). Whole genome sequencing and structural 
variation analysis of this data further confirmed that the Nkx1.2 gene was the only locus 
modified by integration of GFP-T2A (Fig. 2H). Using CRISPR-Cas9 approach we thus generated 
a GFP-Nkx1.2 hESC line bearing a mono-allelic insertion of the GFP-T2A specifically in the 
Nkx1.2 locus.  
Differentiation of this GFP-Nkx1.2 reporter line using the dSMADi-RA protocol was then 
characterized by Western blot; revealing GFP expression up to day 5 (Fig 2I), including low-level 
GFP in hESC, (consistent with detection of Nkx1.2 in H9 hESCs) (Fig. 2E). Flow cytometry 
(without GFP antibody) further confirmed GFP expression at D3 in GFP-Nkx1.2 cells compared 
with auto-fluorescence profile of wild-type H9 differentiated in parallel, which was then lost as 
cells differentiate (D7) (Fig. 2J). To confirm that Nkx1.2 locus modification did not impair 
differentiation we used immunocytochemistry and flow cytometry to assess Sox2/Bra co-
expression on D3 (Fig. S2) and RT-qPCR (Fig. S5) to profile expression of marker genes during 
dSMADi-RA differentiation. These analyses indicated that the engineered line made NMP-like 
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cells and that its differentiation was comparable to that of the parental H9 line (Figs S2, S5, 2A-
E). Similar results were obtained with a second GFP-Nkx1.2 line, demonstrating the 
reproducibility of this approach (Fig. S6). 
 
Identity and conservation of human NMP transcriptional signature 
We next used this GFP-Nkx1.2 cell line to select for high GFP-expressing cells on D3 using FACS 
(see Materials and Methods) and generated RNA-Seq data for D3. This was compared with 
RNA-Seq data for D8 NPs (not subjected to prior selection) and published RNA-Seq data for H9 
hESCs (Chu et al. 2016). This included expected NMP-associated genes Bra, Cdx1, Sp5, 
Wnt8A/C, Fgf17, but also new genes, such as membrane protein of unknown function Unc93a 
and GPRC5a, an orphan G-protein-coupled receptor responsive to retinoid signalling (Cheng 
and Lotan 1998). Some enriched genes (Fgf17, GPRC5A, Unc93A) were then validated by RT-
qPCR, including a gene not in the top list (Shisha3), which attenuates FGF and Wnt signalling 
(Yamamoto et al. 2005) (Fig. 3B). 
 This human D3-NMP-like gene list was next compared with that for genes uniquely 
upregulated in in-vitro-derived mNMPs (Gouti et al. 2014). This identified 31 conserved genes 
(Fig. 3C). These include transcription factors known to be expressed in mNMPs, Bra, Nkx1.2 and 
Mixl1, but also newly implicate Mkx (mohawk /Irx1L), (Liu et al. 2006), Alx3 (Beverdam and 
Meijlink 2001) and Runx3 as transcriptional regulators. Predicted signalling pathways, Wnt 
(Wnt8A, Wnt5A, Dkk4) and TGF antagonism (Fst, Follistatin) were also represented, along with 
genes implicating new signalling activities. These include 4 solute carriers (SLC13A5, SLC38A8, 
SLC43A1, SLC6A7). SLC6A7 is a member of the gamma-aminobutyric acid (GABA) 
neurotransmitter gene family and two further genes mediating GABAergic signalling are also 
conserved: GAD1 (glutamic acid decarboxylase), which synthesizes GABA from glutamate and 
is transcribed in the mouse tailbud (Maddox and Condie 2001) and GABA receptor 
GABBR2/GPRC3B. In neurons, GABA-B receptors can trigger inactivation of voltage-gated 
calcium channels (Padgett and Slesinger 2010). Two further conserved NMP genes, CACNA1C 
(a calcium-channel auxiliary subunit/CaV1.2) implicated in maintaining calcium-channel 
inactivation (Soldatov et al. 1997) and ATP2A1 (a calcium transporting ATPase) which maintains 
low cytoplasmic calcium (Shull et al. 2003), may additionally operate via different mechanisms 
to restrict intra-cellular calcium. This is consistent with the requirement for calcium signalling 
for neural induction, as indicated by Sox2 transcription, in chick embryos (Papanayotou et al. 
2013). Indeed, Sox2 transcripts are characteristically low in mNMPs (Gouti et al 2014). To test 
this predicted increase in calcium signalling during neural differentiation we assessed this in D3 
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NMP-like cells and D8 neural progenitors using a fluorescence based reporter (Fluo3-AM), 
which binds free intracellular Ca2+ (Tsien 1981). This revealed elevated calcium signalling in 
neural progenitors cells in comparison with NMP-like cells (Fig. S7). 
 
As there are not only species differences between these data sets, but also in vitro 
protocol variation, we additionally compared the human D3/NMP-like molecular signature with 
those obtained for mouse embryonic NMPs at E8.5 and E9.5 using single-cell-RNA-Seq (Gouti 
et al. 2017). This identified 23 conserved genes (Fig. 3D). This again included GAD1 and another 
GABA receptor, GABRG1, belonging to the type-A family, shown to regulate stem cell 
proliferation (Andang et al. 2008). GABA biosynthesis is an output of the tricarboxylic acid (TCA) 
cycle, input to which can come from glycolytic metabolism, which was recently shown to 
operate in tailbud progenitor cells (Bulusu et al. 2017; Oginuma et al. 2017). It will therefore 
be important in the future to understand the relationship between this metabolic state and 
GABA production in axial progenitors (Fig. 3D).  
 
Transcriptomic characterization of the differentiation protocol  
These RNA-Seq data also helped to characterize cell types generated with the dSMADi-RA 
differentiation protocol. The mesendoderm marker Sox17 was not detected, nor were 
transcripts from anterior neural genes (Foxg1, En2 and Dlx2) in any condition (<10 reads), while 
Otx2, which is initially expressed in the early epiblast and primitive streak (Ang et al. 1996; 
Henrique et al. 2015), declines sharply from hESCs (Fig. 4A). This is not surprising given hESC 
exposure to FGF and Wnt signalling for 3 days to generate NMP-like cells, at which time cells 
begin to express a range of Hox genes, including a1, b4 and a7, (Fig. 4B). In this assay, therefore, 
NMP-like cells possess a posterior identity prior to their direction along the neural 
differentiation pathway. Components of signalling pathways known to regulate embryonic 
NMPs, reviewed in (Henrique et al. 2015), exhibited expected gene expression profiles (Figs 4C, 
D, E). High-level transcription of neural progenitor and neurogenic genes (Fig 4F) was detected 
on D8 and correlated with increased retinoid signalling reported by RARb transcription (Fig. 
4G). The expression of both BMP and Shh pathway genes (Fig. 4H,I) on D8 suggested that 
induced spinal cord progenitors are exposed to dorsal (BMP) and ventral (Shh) patterning 
signals. However, while dorsal neural progenitor and neural crest associated genes were 
expressed along with some more ventral progenitor genes (Fig. 4J), ventral-most markers 
Nkx2.2 and floor plate marker FoxA2 were not detected at D8. The early transcription of neural 
crest genes in this differentiation assay further suggests that, as in the elongated embryonic 
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body axis and in mouse ES-derived in vitro spinal cord assays, dorsal progenitor cell types 
emerge prior to ventral progenitors (Meinhardt et al. 2014). 
 To establish whether ventral cell types, such as motorneurons, can be derived from 
day 3 NMP-like cells we further adapted the neural differentiation regime, after (Amoroso et 
al. 2013), including extension of the culture period to 21 days. This reproducibly generated 
motorneurons, identified as cells co-expressing Islet1 and HB9 (Figure S8). 
 
Guided by signalling in model vertebrate embryos we have devised a protocol for the 
robust differentiation of human spinal cord progenitors from NMP-like cells, which could be 
further differentiated in to expected spinal cord cell types, such as motorneurons. This protocol 
can be used for future mechanistic and translational approaches, including development of 
human neuroepithelial cell behaviour assays. The GFP-Nkx1.2 reporter line allowed selection 
of high Nkx1.2 expressing cells on D3 and has the potential to be further engineered to report 
for Bra, select for later Nkx1.2+/Bra- cells and so identify early changes in neural differentiation. 
These RNA-Seq data not only served to validate this differentiation protocol and uncover a 
conserved NMP-like transcriptional signature, but also identified potential new signalling 
pathways, including those mediated by GABA and calcium, involved in the regulation of the 
NMP cell state.  
 
Materials and Methods 
Human ES cell culture and differentiation 
Human ES cells (H9, WiCell; SA81, SA121 both Cellartis AB) and human iPS cells (ChiPS4, 
Cellartis AB) were maintained as feeder-free cultures in DEF medium (Cellartis AB) 
supplemented with bFGF (30 ng/mL, Peprotech) and Noggin (10 ng/ml, Peprotech) on 
fibronectin (Millipore, 5 g cm-2) coated plates, and enzymatically passaged to single cells using 
TrypLE select (Life Technologies) according to the manufacturers recommendations. Meta-
data for quality control and passage numbers for all pluripotent stem cells (PSC) used in this 
study are provided in Supplementary Data 1. For single cells passaging, the medium was 
supplemented by addition of the Rho kinase inhibitor Y-27632 (10 M, Tocris). All experiments 
with hESCs were approved by the UK Stem Cell Bank steering committee (SCSC14-28 and 
SCSC14-29). 
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For differentiation assays, PSC were plated on Geltrex matrix (20 g cm-2, Life 
Technologies) at a density of 4x104 cells cm-2 in DEF medium supplemented with bFGF, Noggin 
and Y-27632 as above, and cells allowed to attach for 24 hours. To start differentiation, the 
medium was changed to Neurobasal supplemented with 1x N2, 1x B27 supplements (all Life 
Technologies), Chiron99021 (3 µM, Tocris) and bFGF (20 ng ml-1) and cells incubated for 48 
hours. The medium was then changed to Neurobasal supplemented with 1x N2, 1x B27, 
Chiron99021 (3 µM, Tocris), bFGF (20 ng ml-1), Noggin (50 ng ml-1) and SB431542 (10 M, 
Tocris) and cells incubated for a further 24 hours to obtain NMP-like cells. 
For further differentiation, NMP-like cells were dispersed using PBS-EDTA 0.5 mM and 
seeded at a density of 2x105 cells cm-2 on Geltrex matrix (20 g cm-2) in Neurobasal 
supplemented with 1x B27, 1x N2, all-trans retinoic acid (100 nM, Sigma Aldrich) and Y-27632 
(10 M, Tocris), and allowed to attach overnight. Cells were then cultured in Neurobasal 
supplemented with 1x N2, 1x B27 and all-trans retinoic acid (100 nM) for the indicated time to 
obtain later stage progenitors.  
NMP-like cells were differentiated into motorneurons using a protocol adapted from 
(Amoroso et al. 2013). Briefly, day 3 NMP-like cells were replated as described above and 
allowed to attach overnight. The medium was then changed to Neurobasal supplemented with 
1x N2, 1x B27, all-trans retinoic acid (100 nM), L-Ascorbic acid 2-phosphate (400 nM, Sigma 
Aldrich) and BDNF (20 ng ml-1, Peprotech) and the cells cultured for 48 hours. The medium was 
then further supplemented by the addition of C25Il Shh (20 ng ml-1, Dundee Cell Products) and 
cells cultured for 17 days changing the medium every 48 hours.  
 
RTqPCR 
Total RNA was extracted using the RNEasy mini kit (Qiagen), following the manufacturer’s 
instructions, with the addition of a DNAse digestion step performed on the column for 15 min 
with RQ1-DNase (Promega). After initial denaturation for 5 min at 70°C in presence of 1 g 
random primers, 500 ng of RNA per sample were reverse transcribed for 1h in 20 L reaction 
volume containing 0.5 mM dNTPs, 5 mM MgCl2, 1X ImProm-II RT buffer, 20 U RNasin and 160 
U of ImProm-II RT (Promega). Samples were incubated for 15 min at 70°C to stop the reaction. 
qPCR analysis was performed using primers described in table 6 on either a Mastercycler 
RealPlex2 (Eppendorf) or an AriaMX (Agilent) device in presence of PerfeCTa SYBR Green 
SuperMix for iQ (Quanta Biosciences) or BrilliantIII SYBRgreen PCR MasterMix (Agilent) 
respectively. Relative expression was calculated using the Ct method, normalizing each gene 
of interest to Gapdh levels. 
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 Western blot 
Western blots were performed using standard protocols. Briefly, proteins were extracted using 
RIPA buffer (150 mM sodium chloride, 1.0% Triton X-100, 0.5% sodium deoxycholate, 0.1% SDS 
(sodium dodecyl sulphate) and 50 mM Tris, pH 8.0). Cell extract was incubated on ice for 30 
min in presence of DNAse (Universal Nuclease, Pierce) and spun down for 20 min at full speed. 
Protein concentration in supernatant was determined using a Bradford Assay with a BSA 
standard curve ranging from 0-2 mg/ml. The samples were diluted in NuPage 4x sample buffer 
(LifeTechnologies) and loaded onto a 4-12% gradient gel (Novex NuPAGE, LifeTechnologies). 
Western blots were performed using standard procedures and antibodies used at the following 
concentrations: anti-GAPDH 1 µg/mL (ab9484, abcam), anti-GFP 1 g/mL (ab6673, abcam). 
Detection was performed with anti-goat Dylight 6800 conjugate (1:10000, LifeTechnologies) 
and anti-mouse DyLight™ 800 conjugate (1:10000, LifeTechnologies) on a LI-COR imaging 
device (BioSciences). 
 
Immunofluorescence microscopy 
Cells were fixed by adding formaldehyde to a final concentration of 3.7% in PBS, then 
permeabilized and blocked in PBS/0.1% TritonX-100/4%(w/v)BSA. Incubation was performed 
at 4°C overnight with primary antibodies at the following concentrations: goat anti-Brachyury 
1 g ml-1 (AF2085, R&D), rabbit anti-Sox2 5 g m-1 (ab5603, Millipore), rabbit anti--III-tubulin 
1 g ml-1 (T2200, Sigma aldrich), mouse anti-HB9 1.75 g ml-1 (81.5C10, Developmental Studies 
Hybridoma Bank), rabbit anti-Islet1 2.5 g ml-1(ab20670, Abcam). Fluorochrome-conjugated 
secondary antibodies used were the following:  anti-goat Alexa647-conjugated 4 g ml-1 
(A21447, Invitrogen), anti-rabbit Alexa488-conjugated 4 g ml-1L (A21206, MolecularProbes), 
anti-mouse Alexa594-conjugated 4 g ml-1L (A11032, MolecularProbes). Observations were 
carried out with a DeltaVision fluorescence microscope (GE Healthcare), and images were 
acquired using the softWoRx software, except images in Figure S8 which were captured on a  
Zeiss LSM 710 confocal microscope. 
 
Flow cytometry analysis of protein expression profile 
Cells were harvested using TryLEselect, fixed for 10 min in 4% paraformaldehyde and re-
suspended as single cells in PBS 1%BSA. An additional 10 min methanol fixation step was added 
for Sox2 and Brachyury detection. Primary antibodies were incubated for 1 h at room 
temperature in PBS 4% BSA, cells were then washed and incubation with secondary antibodies 
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performed for 30 min at room temperature. Antibody used are the followings: goat anti-
Brachyury 1 g/mL (AF2085, R&D), rabbit anti-Sox2 5 g/mL (ab5603, Millipore), anti-goat 
Alexa647-conjugated 2 g/mL (A21447, Invitrogen), anti-rabbit Alexa488-conjugated 2 g/mL 
(A21206, MolecularProbes). After washes, fluorescence was measured on a FACSCanto 
cytometer (BD Bioscience) and results analyzed using FlowJo software. Quadrant gates used to 
estimate the percentage of positive cells were designed based on fluorescence levels detected 
in the control samples processed without primary antibodies.  
 
GFP-Nkx1.2 engineering  
GFP-Nkx1.2 engineering  
The donor plasmid construct, pDonorNkx1.2NterKI, was synthesized by GeneArt. The vector is 
based on a pMK-RQ backbone and contains a Kanamycin resistance cassette and the GFP-T2A 
insert flanked by 500 bp homology arms for recombination to the Nkx1.2 5’ end. The second 
plasmid used, px335Nkx1.2NterKIas, encoded the Cas9D10A nickase (Cong et al., 2013) and the 
antisense gRNA (asgRNA GCCCACGGGCCGGCGGTCGG). A third plasmid, 
pBABEDpU6Nkx1.2NterKIs, included the sense gRNA (sgRNA GCTGGCATGGCAGGACGGCG) and 
a puromycin resistance cassette to select transfected cells. CRISPR-Cas9 mediated gene 
targeting was performed as follows; H9 hESC were dispersed to single cells using TryLE select 
(Life Technologies) and re-suspended in DEF medium in the presence of Y-27632 (10mM, 
Tocris). For transfection, 5x106 cells were pelleted by centrifugation at 300 xg for 3 minutes, 
washed with PBS and re-suspended in 100L buffer R (Neon Transfection Kit, Life Technologies) 
containing 4g of pDonorNkx1.2NterKI, 2g of px335Nkx1.2NterKIas and 2g of 
pBABEDpU6Nkx1.2NterKIs. Electroporation was performed with the Neon Transfection System 
(Life Technologies) using the following parameters: 1 pulse, 1150V, 30ms. Transfected cells 
were plated and allowed to recover for 36 hours, puromycin selection (1 g ml-1) was applied 
for a further 36 hours. Clones were left to grow until easily visible, hand-picked and seeded 
back in 96 well plates before being amplified. Screening of the clones for GFP integration was 
performed by PCR using primers amplifying across the insertion sites 
(GFPcheckFw1+GFPcheckRev1, see the table below for sequences) (Fig. 2G). Correctly targeted 
integration of the GFP-T2A sequence was checked in 40 transformed hESC clones by PCR across 
the integration site. Overlapping PCR amplification products spanning the locus from outside 
the homologous region to inside the GFP sequence on both sides of the integration were 
sequenced (GFPcheckFw1+GFPcheckRev2 and GFPcheckFw2+GFPcheckRev1, see the table 
below for sequences). Five clones were found to include the GFP-T2A sequence at the correct 
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locus and these were all heterozygous for GFP-Nkx1.2 (Figure 2G). PCR bands obtained for GFP-
Nkx1.2 clone 5 were sequenced to check for integrity of the recombination borders and 
absence of mutations. Results were combined and detailed sequence of the engineered allele 
was obtained (Figure S4). 
 
primer sequence 
GFPcheckFw1 CAGTTGCATCCCCAAGTCTAAGG 
GFPcheckFw2 AGTGGAAGCAAAAGACTGAGAGTC 
GFPcheckRev1 TTTCTGTGGGTCCAGGATGTCCA 
GFPcheckRev2 GTTGAGTCTGGGGAGCTTGAGC 
 
Whole Genome Sequencing 
gDNA was extracted from GFP-Nkx1.2 hES cells using the DNeasy Blood and Tissue Kit (Qiagen), 
according to the manufacturer’s instruction. Whole Genome Sequencing was performed by 
Novogene and deposited in ENA accession number XXXX). Briefly, a library was generated from 
1 g gDNA using Truseq Nano DNA HT sample preparation Kit (Illumina) following 
manufacturer's recommendations and sequenced on an Illumina platform. After quality 
control, BWA (version 0.7.8‐ r455) was used to align reads to the genome, using the 
1000Genomes (GRCh37+decoy) human as reference. BAM files were sorted using SAMtools 
(version 1.0) and read duplicates identified using Picard (version 1.111). Structural variation 
(SV) analysis was done using Delly (v0.7.2) (Rausch et al. 2012), and ANNOVAR (version 
2015Mar22) was used to annotate the SV. An average coverage of 33X was obtained (depth 
>20X for 92% of bases).  
 
Cell purification for RNA-Seq analysis by FACS 
Cells were sorted on a BD Influx (Becton Dickinson) cell sorter using the 100 µm nozzle. FSC vs 
SSC was used to identify live cells and then FSC-A vs FSC-W to identify single cells. The GFP 
positive cells were identified using 488 nm laser light and the parameters GFP (530/40) and PE 
(580/30). The gate to identify GFP positive cells was set using a GFP negative control (H9 cells 
differentiated in parallel) and events that fell into this gate were sorted to more than 97% 
purity. 1.5 million GFP positive cells sorted at day 3 were used per sample for RNA extraction. 
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Library preparation for RNA-Seq and Sequencing 
Total RNA was extracted using the RNEasy mini kit (Qiagen), following the manufacturer’s 
instructions, with the addition of a DNAse digestion step performed on the column for 15 min 
with RQ1-DNase (Promega). RNA concentration was measured on a Qubit device using Qubit 
RNA BR assay kit (ThermoFisher), and quality was checked on a TapeStation instrument 
(Agilent). Individually labeled libraries were prepared from 1 g of RNA per sample using the 
TruSeq® Stranded mRNA Library prep kit (Illumina), according to manufacturer’s instructions. 
2 L of Spike-ins (1/100 dilution ERCC Spike-in controls Mix1) was added per sample. Libraries 
were pooled and sequencing was performed on a NextSeq (Illumina) at the Tayside Center for 
Genomic analysis (Ninewells, Dundee) as follows: high output run, 2x75bp paired end 
sequencing, between 35 and 46 million uniquely mapped reads obtained per sample (12 
samples multiplexed). RNA-seq data are available in the ArrayExpress database 
(http://www.ebi.ac.uk/arrayexpress) under accession number E-MTAB-6680. 
 
RNA-Seq analysis 
RNA-Seq reads were mapped to the reference genome (version GRCh38, release 87) using STAR 
2.5.2b, using stranded option. Typically, about 92% of reads were mapped uniquely (except for 
D3(NMP-like) replicate 4, where uniquely mapped reads were at 86.8%). Read counts per gene 
were found in the same STAR run. Data from (Chu et al. 2016) were re-analysed in the same 
fashion, however, we point out that these were single-end non-stranded reads.  For the 
following analysis, 4 biological replicates were used for D3(NMP-like) and 2 for D8 samples. 
Differential expression was performed with edgeR 3.16.5, for each pair of conditions 
independently. Benjamini-Hochberg multiple-test correction was applied to test p-values. 
Human NMP-like genes (Fig. 3A) were determined by selecting genes using the following 
criteria: at least 10 read counts in D3(NMP-like), significantly enriched (p value < 0.01) in 
D3(NMP-like) compared to both hESC and hD8 samples, with a foldchange >2. Time-dependent 
properties of genes were studied using intensity profiles hESC-D3(NMP-like)-D8. Each point in 
the profile is a DESeq-normalized mean gene count across replicates. To make profiles 
comparable, they were normalized to their mean across conditions, so the mean of each 
normalized profile is 1.  
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Comparisons between this human NMP-like signature and mouse NMP genes 
identified elsewhere was performed based on gene names. Gene list in figure 3C was obtained 
by comparing human NMP-like gene list (this study, full list in table S1) and bulk-RNA-Seq of 
mESC-derived NMPs (table S1 from Gouti et al., 2014). Gene lists in figure 3D were obtained by 
comparing human NMP-like gene list (this study, full list in table S1) and extended single cell 
RNA-Seq data obtained for NMP from e8.5 and e9.5 embryos (Gouti et al., 2017).  
 
Calcium imaging 
To visualize Ca2+ levels, D3 NMP-like cells or D8 NPs (200K cells/cm2) were differentiated as 
described in Figure 1B  and incubated in a mixture of Fluo3, AM (Invitrogen; stock 1 mM in 
DMSO, delivered to cells 1μM) at 37°C for 30 min, rinsed with Neurobasal medium (Gibco) 
supplemented as appropriate for D3 or D8 and left to recover for 1h. Fluo3,AM was then 
excited at 488 nm and the fluorescence generated was imaged by Deltavision Core microscope 
system in a WeatherStation environmental chamber maintained at 37°C. The D3 NMP-like and 
D8 NP medium was buffered with a 5% CO2/95% air mix and maintained in a humid chamber. 
Images were acquired using an Olympus 20x 1.30 NA objective using a Xenon light source and 
a CoolSnap HQ2 cooled CCD camera (Photometrics). Images were deconvolved and maximum 
intensity projections of Z-stacks were made using SoftWorx imaging software (Applied 
Precision). To provide a positive control for response to calcium influx, D3 NMP-like and D8 NP 
cells were incubated with A23187  (Sigma C7522) 10 μg/ml in 0.1% DMSO in Neurobasal) at 
37°C for 20 min, rinsed, incubated in with Fluo3, AM for 30 min and then rinsed in Neurobasal 
medium. The fluorescence generated was imaged as above. The raw data were then quantified 
using Image J plugin Heatmap Histogram. Data and statistical analyses are presented in Figure 
S7 and legend. 
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Figure 1 Protocol for neural differentiation of human NMP-like cells 
A. Schematic of mouse E8.5 caudal embryo. Selected progenitor cell marker genes and 
signalling pathways operating during posterior neural differentiation. B. Schematic of the 
developed differentiation protocol, including a dual-SMAD inhibition step (dSMADi-RA), and 
immunocytochemistry for Bra and Sox2 in day 3 NMPs (3 independent experiments). C. RTqPCR 
showing Pax6 in H9-line differentiated as in B, +/-100 nM RA from day 3. D. RTqPCR for Pax6 in 
cells differentiated as in B, with varying SMAD inhibitor inclusion day 2-4. RTqPCR graphs 
represent expression normalized to Gapdh and relative to hESC levels (3 independent 
experiments, error bars are SEMs, and significant differences, ****pvalue <0.0001, 
***pvalue<0.001, **pvalue<0.01, *pvalue<0.05 (ANOVA test), here and for all subsequent 
RTqPCR data. 
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Figure 2 RTqPCR for selected genes during dSMADi-RA differentiation and generation of a GFP-
Nkx1.2 reporter line 
A-E. RTqPCR assessing relative expression of key marker genes in H9-cells exposed to dSMADi-
RA protocol (Fig. 1F). A. Declining expression of pluripotency genes Oct4 and Nanog. B. Sox2, 
Bra and Cdx2 expression dynamics. C. HoxB4 and HoxC6 during differentiation. D. Expression 
neural progenitor marker Pax6. E. Wnt8a/c and Nkx1.2, characteristic of preneural progenitors 
and NMPs. F. Experimental strategy schematic: H9 hESC were engineered using CRISPR/Cas9, 
knocking-in the GFP-T2A sequence upstream exon 1 of Nkx1.2. Positions of the gRNAs, and 
homologous regions used in the repair template are indicated. G. PCR amplification of the 
Nkx1.2 locus using primers framing the insertion site. H9: untransfected control, 1-3: GFP 
negative clones, 5 and 6: clones containing the GFP insertion (GFP KI = knockin, WT = wildtype 
allele). H. Whole genome sequencing of GFP-Nkx1.2 clone 5. Structural variation analysis 
relative to GFP-T2A sequence: FT: per sample genotype filter; TCHR: chromosome for the 
translocation breakpoint coordinate; TSTART: translocation breakpoint coordinate; SVType: 
structural variation type; TRA: translocation. I. Western blot of GFP during differentiation of the 
GFP-Nkx1.2 line. J. Flow cytometry of GFP expression day 3 and day 7: % of maximum-intensity 
for GFP-channel is plotted, representative values of at least 2 experiments.  
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Figure 3 Characterization and conservation of Human D3(NMP-like cell) transcriptome  
A. Genes preferentially expressed in human D3(NMP-like cells) compared to hESC and hD8 
neural progenitors (NP). Genes were considered preferentially expressed in hD3 when >2-fold-
change between hD3 and both hESC and hD8 (TableS1). B. RTqPCR for subset of D3-enriched 
genes. C.  Comparison of human NMP-like-enriched genes (this study) and bulk-RNA-Seq of 
mESC-derived NMPs (Gouti et al., 2014). D. Comparison of NMP-like-enriched genes in human 
(this study) with mouse embryo eNMP transcriptional signatures obtained by comparing 
scRNA-Seq data for e8.5 and e9.5 embryos (Gouti et al., 2017). 
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Figure 4 Expression of selected genes across 3 conditions analysed by RNA-Seq. 
A. Anterior neural marker genes, presented as read counts. B. Main Hox genes expressed at D3 
and D8. Selected components of C. FGF, and D. Wnt signaling pathways. E. Selected BMP/TGF 
inhibitors. F. Neural progenitor and neurogenic genes, and G. Retinoid receptor RAR during 
hNMP-like cell differentiation. Selected components of H. BMP, and I. Shh signalling pathways. 
B-I relative expression of each gene normalized to its mean expression across all conditions 
SEMs for each gene are shown. J. Table of neural crest, dorsal and ventral progenitor genes 
induced during dSMADi-RA differentiation. Fold change between D8 and D3(NMP-like) time 
points, mean read counts for D3(NMP-like) and D8 are shown.  
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Figure S1Assessment of neural differentiation of hNMP-like cells in basic differentiation conditions
A. Basic protocol for in vitro generation and neural differentiation of  hNMP-like cells as in (Gouti et al., 2014) 
and B. co-expression of Bra/Sox2 proteins on day 3  of protocol  shown in A, detected by immunocytochemistry 
(3 independent experiments) and RTqPCR assessing relative expression of Bra during generation of NMP-like 
cells (SA121 line). C. RTqPCR for Pax6 in SA121 cell line cultured as indicated (SA121-line exhibits low-level 
Pax6 in hESC, while H9-line does not and so H9 was used for all subsequent experiments). D. RTqPCR for 
Pax6 in H9 cells cultured as indicated. This basic protocol did not elicit Pax6 expressing cells in either SA121 or 
H9 lines. This contrasted with the positive control for Pax6 transcription provided by a protocol for inducing 
anterior neural progenitors, exposure to Noggin 50 ng/ml and the TGF receptor type 1 inhibitor SB431542 10 M 
following removal of self-renewal conditions (dual SMAD inhibition, (Chambers et al. 2009), shown in C. 
RTqPCR graphs represent expression normalized to Gapdh and relative to hESC levels and all constitute 3 
independent experiments, error bars are SEMs. Significant differences are represented here and for all 
subsequent RTqPCR data: ****p value <0.0001, ***p value<0.001, **p value<0.01, *pvalue<0.05 (ANOVA test, 
except for figure S1B:T-test).
Development 145: doi:10.1242/dev.166215: Supplementary information
D
ev
el
o
pm
en
t •
 S
up
pl
em
en
ta
ry
 in
fo
rm
at
io
n
- antibody 
control 
+Sox2/+Bra
   antibodies  
AF 647: Bra AF 647: Bra 
A
F 
58
8:
 S
ox
2 
A
F 
48
8:
 S
ox
2
H9 control
 D3 (NMP-like) 
GFP-Nkx1.2
D3 (NMP-like)
0%0%
93.2% 89.7%
AF 647: Bra 
Secondary 
antibodies
only 
control 
A
F 
48
8:
 S
ox
2
Figure S2 Co-expression of Sox2 and Bra proteins in hD3(NMP-like) cells
Expression of Sox2 and Bra was analyzed by flow cytometry in D3 cells derived from H9 cell line (left panels) and 
H9-GFP-Nkx1.2 cell line (right panels). Upper panels: no antibodies control, middle panels: staining with anti-
Sox2 and anti-Bra antibodies, bottom graph: secondary antibodies alone (control). The quadrant for quantification 
of co-expression levels was defined based on fluorescence observed without primary antibody application (bottom 
graph). The percentage of co-expression for each panel is indicated at the upper right corner (purple). 
Representative experiment of 2 independent experiments.
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Figure S3 Robust differentiation of spinal cord progenitors from NMP-like cells in an iPS cell line
A. Schematic representation of the differentiation protocol used on the ChiPS4 cell line, including a dSMADi step 
from end of day 2 to end of day 4. B. Expression profile of selected genes over time in chiPS4 cells submitted to the 
differentiation protocol presented in A. Graphs represent the expression of each individual gene normalized to 
Gapdh and relative to hiPSC levels. RTqPCR data represents average of 3 independent experiments, error bars 
SEM.
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AACCCTCCCTATAGGGGCGATTGGAGCTCCCGCGGTGCGGCCGCTCTAGAACTAGTG
GATCCCCCGGGCTGCAGCGACCAATGTGGAATTCGCCCTTAGTGGAAGCAAAAGACT
GAGAGTCCGGGATTTTCTCCCTCCGTTTCTGAGACAGCAGGATGTACTAAAAAAGCA
CTGACTGGTCCAGTAGAAGACCGAGGTCCAAACCCAGACTCTGTCACCAACTCACAG
TGACCCTGGGGAAATCTTTTCTTACCTTTGAACCTCGATTTCCTCATCTTTAAAACG
GGGACAGTGGTCTGTGCCACGTGACGCCCATCTCACAGGGATGCTCAAATAATCAAA
AGAGATCGTGCAAGCCTCAGGGCTTTGTGAACGCTAAACTGTGAGAACGTGAGGGAT
TTTACCTCCGAGGTAACCGGGTCTGAAGCTATTACAGTAATTCACTGGCGGGGAAGG
AGATGCGCTGAGCATTGCCTGGGAGTAAGCAGTCCTGGCCTCAGTTGCATCCCCAAG
TCTAAGGCGGGTGCACCGGAGAAAGGGAACAAACTCAAGTCACAGAGGTGTGTGTGT
CGGGGTGAGGGATCCCCGGGATGGAAGCCTCCCTCGCGCCCTCGGAGAGTCCCAGAG
GGTTGGGCGGAGGCGCGCGGAGACGACAACACTGTCCCCGCGGTCGCGCGCACCGGG
CGCGCGGAGGCTTCCCCGAGCCCAGGCAAGCGGCCGCGGCACAGCGCCTGATAGTCC
CGAGGCTGGCCCGGGCTGCGCCGGTGCCAATCGGCGCGCAGCCCCCCGCGGCGCTCT
CCCCGCCCCGCCTCCCCGCCCCCCTCCCCAGCTTCACTTGGCAGCGCGGACCCGGCT
CCTGGCTGGAAAGCTACCGCCAAGCCACAGCCGAAGGCAAGCCCGAGCGGCGCCATC
CCCAACCCCGCGCCGCCGACCGCCGGCCCGTGGGCGACGGGCATGGTGAGCAAGGGC
GAGGAGCTGTTCACCGGGGTGGTGCCCATCCTGGTCGAGCTGGACGGCGACGTAAAC
GGCCACAAGTTCAGCGTGTCCGGCGAGGGCGAGGGCGATGCCACCTACGGCAAGCTG
ACCCTGAAGTTCATCTGCACCACCGGCAAGCTGCCCGTGCCCTGGCCCACCCTCGTG
ACCACCCTGACCTACGGCGTGCAGTGCTTCAGCCGCTACCCCGACCACATGAAGCAG
CACGACTTCTTCAAGTCCGCCATGCCCGAAGGCTACGTCCAGGAGCGCACCATCTTC
TTCAAGGACGACGGCAACTACAAGACCCGCGCCGAGGTGAAGTTCGAGGGCGACACC
CTGGTGAACCGCATCGAGCTGAAGGGCATCGACTTCAAGGAGGACGGCAACATCCTG
GGGCACAAGCTGGAGTACAACTACAACAGCCACAACGTCTATATCATGGCCGACAAG
CAGAAGAACGGCATCAAGGTGAACTTCAAGATCCGCCACAACATCGAGGACGGCAGC
GTGCAGCTCGCCGACCACTACCAGCAGAACACCCCCATCGGCGACGGCCCCGTGCTG
CTGCCCGACAACCACTACCTGAGCACCCAGTCCGCCCTGAGCAAAGACCCCAACGAG
AAGCGCGATCACATGGTCCTGCTGGAGTTCGTGACCGCCGCCGGGATCACTCTCGGC
ATGGACGAGCTGTACAAGTCCGGACTCGGATCCGAGGGCAGAGGAAGTCTTCTAACA
TGCGGTGACGTGGAGGAGAATCCCGGCCCACTGGCATGGCAaGAtGGtGGtGCCAAG
GCGGCTCCCTCCCACCACAAGATTTCTTTCTCTGTCCTGGACATCCTGGACCCACAG
AAATTCACCCGCGCAGCGCTCCCTGCCGTGCGCCCGGCTCCCCGGGAAGCCAGGAAA
AGTTTGGCGGAGGTCGAAGCGGGGAAAGATGCCAGCTCCAGGGACCCTGTCCGACAG
CTGGAGACCCCTGGTAAGATGCAAGGCGGCCCCGGCCCCAGGAGGCCTCAGCCCCAA
CAATGCGGAGTGTATGGGGGAACAGCCGGGCCCGGTGAGTGGCCCTTAACAGCGTCT
TCCTCAGAGAGAAGGCGCACGGGACCGGGTGCGAAGTGTAGCCCCCGCCTCGGACTT
GGATAGAGGCAGAGAGGAGGCTCCCCGCATTACAGGGCAGGGATTTGCCGCATCCCT
GCTCACCCGCCAAGCTCACCCGCACCACAGTTCTGATGCTCGCGGTGGAAACTTACC
TGGCGCCTGTCTTGCCAGGCTTACTCATTTATCGGGCATTTAATGCGCTTGCCACGT
GCTAGGACCTGGGCTAAGGGCTGGGATAAAGGTGATGAAAACTTCGGAACCTGAGAG
ATGGACAGCATCATTAACATCACCTCCATTTTATGGATGGGGGAGCTGACGCTAAGG
CTTGCGCCGGGGGTCTTCGTGAGTAGCGAGGTCAGGTGCCACCCGGAGACGCCTGCG
GGGCTGGGCTGCCCCAGGCGCTCAAGCTCCCCAGACTCAACTGCCCGCTACCTCGAG
GGCGCCACGCCGGCGAGATCTTGATCACCTAGGGGGCCCGACGTCGCTGGTTACACC
TTAAGCGGGAA 
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Legend: 
Plamid sequence 
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gRNA (antisense and sense) 
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Nkx1.2 Exon1 
repeats 
Figure S4
Sequencing of the GFP-T2A insertion site in the correctly targeted clone used in this study. Grey: 
plasmid sequence, highlighted yellow: Primers used for cloning, highlighted blue: gRNA (antisense and 
sense), highlighted green: GFP sequence, orange: T2A sequence, bold black: Nkx1.2 Exon1, peach: 
repetitive sequences.
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Figure S5 Diffentiation evaluation of the GFP-Nkx1.2 clone used in this study
Expression of selected marker genes was analyzed by RTqPCR during differentiation of the GFP-Nkx1.2 line 
following the protocol presented Figure 1B. Graphs represent the expression of each individual gene 
normalized to Gapdh and relative to hESC levels. Average of 3 independent RTqPCR experiments, error bars 
are SEM.
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Figure S6 GFP expression and differentiation profile of a second correctly targeted GFP-Nkx1.2 clone
A. Flow cytometry analysis of GFP expression at D3 (NMP-like) and D7 of the differentiation protocol. % of 
maximum intensity for GFP channel is plotted, geometric mean for each peak is indicated. B. Expression of 
selected marker genes analyzed by RTqPCR during differentiation of the second GFP-Nkx1.2 clone following the 
protocol presented Figure 1B. Graphs represent the expression of each individual gene normalized to Gapdh 
and relative to hESC levels. Average of 3 independent RTqPCR experiments, error bars are SEM.
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Figure S7 Calcium signalling increases as NMP-like cells differentiate into neural progenitors 
Calcium signalling was assessed using Fluo-3, AM in D3 NMP-like cells and in D8 neural progenitors 
(NP). A. D3 NMP-like cells exposed to Ca2+ indicator, Fluo-3, AM (in DMSO/medium), medium alone, 
medium with vehicle DMSO alone, or the calcium ionophore A23187 in the presence of Fluo-3, AM; B. D8 
NPs treated with Fluo-3, AM (in DMSO), medium alone, medium with vehicle DMSO alone, or the calcium 
ionophore A23187 in the presence of Fluo-3, AM. Green emission of Fluo-3, AM excited at 488 nm has 
been pseudo-coloured and presented as a heat-map using the HeatMap Histogram plugin for Image J 
(red=high and blue=low fluorescence); C): Quantification and comparison of calcium fluorescence in D3 
NMP-like cells and D8 NPs exposed to Fluo-3, AM, medium alone, medium with DMSO or the calcium 
ionophore A23187 in presence of Fluo-3, AM. Quantification was made using the total fluorescence 
intensity from 3 images for each condition from 4 independent experiments. Data were analysed using the 
non-parametric Mann-Whitney test with Graphpad Prism V6. Error bars are ± standard deviations. p-value 
**p<0.01. Scale bar = 50 μm. These data show that calcium signalling is higher in D8 neural progenitors in 
comparison with D3 NMP-like cells from which they are derived.
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Figure S8 Motorneuron differentiation from hESC derived NMP-like cells 
H9 ES cells were differentiated into neuromesodermal progenitor-like cells as in Fig1B and then 
differentiated towards motor neurons as described in the Methods. Nuclei were stained with DAPI (A and E), 
and labelled with antibodies against Islet1 (B,D,F and H), beta-III-tubulin (C and D) and HB9 (G and H). 
Motorneurons were identified as cells co-expressing HB9 and Islet1 (Amoroso et al. 2013). Images are 
representative of cells cultured using this protocol in 3 independent experiments starting from the hES cell 
state. Scale bar = 100 μm
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Supplementary data 1 
Quality control and passage numbers for pluripotent cells used in this study 
H9 (WA09) hES cells were purchased from Wicell and were supplied at passage 24. The cells were 
thawed transferred to DEF-CS and cell banks prepared at passage 29. For routine production the cells 
were used between passage 29 and 39. 
SA121 hES cells were purchased from Cellartis AB and were supplied at passage 9. The cells were 
thawed and cell banks prepared at passage 13. For routine production the cells used between 
passage 13 and 23. 
ChiPS4 hiPS cells were purchased from Cellartis AB and were supplied at passage 9. The cells were 
thawed and cell banks prepared at passage 13. For routine production the cells used between 
passage 13 and 23. 
For making the Nkx1.2 GFP knock in line H9 (WA09) cells were transfected at passage 33 and 
monoclonal cell lines banked at passage 40. For routine production the cells used between passage 
40 and 50 
For quality control purposes, representative lots of each cell bank were thawed and tested for post-
thaw viability, and to ensure sterility and absence mycoplasma contamination. After 2 passages the 
cell lines were tested for the expression of pluripotency markers (Oct4, Sox2, Nanog, SSEA-3, SSEA-4, 
TRA-1-60 and TRA-1-81) and differentiation markers (SSEA-1, HNF-3 beta, beta-III-tubulin and smooth 
muscle alpha-actinin) by immunofluorescence, and the ability to form all three germ layers 
when embryoid bodies are allowed to spontaneously differentiate in culture (immunofluorescence 
for HNF-3 beta, beta-III-tubulin and smooth muscle alpha-actinin).  
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Table S1. 
List of genes specifically enriched in human NMP-like cells. 
Human NMP-like genes (Fig. 3A) were determined by selection of RNAseq data using criteria 
indicated in the methods section (at least 10 read counts in D3(NMP-like), significantly enriched 
(p value < 0.01) in D3(NMP-like) compared to both hESC and hD8 samples, with a foldchange 
>2). Using these criteria, 1348 genes were identified as highly expressed in human NMP-like 
cells (D3). Full list including information on the 1348 hNMP-like genes are included in sheet 1. 
Sheet 2 contains the selected dataset used to make figure 3A. Both tables present for each 
gene: gene names and description, mean read counts from independent experiments in hESC, 
D3(NMP-like) and D8, fold change between (D3)NMP-like and hESC conditions (FC NMP-
like/hESC), fold change between (D3)NMP-like and D8 conditions (FC NMP-like/D8), and p-
values associated (p_hECS.NMPlike, p_NMPlike.D8, p_hESC.D8). 
Click here to Download Table S1
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